Consumer Discretionary • Catalog/Specialty Distribution
$85.62 ▼ -0.88
(-1.02%)
MKT CAP: $2.16B • VOL: 330.7K
52W L $55 52W H $97
CNXN // SEC EDGAR XBRL STANDARDIZED FINANCIAL STATEMENTS (FA <GO>)
| LINE ITEM (USD / %) | FY 2025
FILED 2025-12-31 | FY 2024
FILED 2024-12-31 | FY 2023
FILED 2023-12-31 |
|---|---|---|---|
| Revenue (Total Sales) | $2.87B | $2.80B | $2.85B |
| YoY Revenue Growth % | +2.5% | -1.7% | — |
| Gross Profit | $539.3M | $519.8M | — |
| Gross Margin % | 18.8% | 18.6% | — |
| Research & Development (R&D) | — | — | — |
| Operating Income (EBIT) | $99.3M | $97.1M | $103.2M |
| Operating Margin % | 3.5% | 3.5% | 3.6% |
| Net Income (GAAP) | $83.7M | $87.1M | $83.3M |
| EBITDA (Normalized) | $105.2M | $103.1M | — |
| Diluted EPS ($/sh) | — | — | — |
| Operating Cash Flow (OCF) | $65.4M | $173.9M | $198.0M |
| Capital Expenditures (CapEx) | $7.4M | $7.6M | — |
| Free Cash Flow (FCF) | $58.0M | $166.3M | $198.0M |
| FCF Margin % | 2.0% | 5.9% | 6.9% |
| Return on Invested Capital (ROIC %) | 10.9% | 10.5% | — |
| Cash & Short-Term Equivalents | $193.2M | $178.3M | — |
| Total Debt (Short + Long Term) | — | — | — |
| Total Stockholders' Equity | $910.1M | $911.0M | — |
NO QUARTERLY 10-Q XBRL STATEMENTS AVAILABLE IN CURRENT CACHE FOR CNXN.